抗药使用与低型球蛋白血症之间的关联:基于人口的病例对照研究使用数据链接的研究结果
Sarah L Perrott1, Angus D Macleod1
1Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
Neuroepidemiology
|September 21, 2023
概括
抗药物 (AED) 与较高的低球蛋白血症风险有关,这种情况可能会增加感染易感性. 特定的AED和累积暴露显示了剂量-反应关系,这表明存在潜在的因果关系.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 的研究研究.
背景情况:
- 在患者中,有证据表明感染 (不包括肺炎) 的死亡率增加.
- 作为潜在的感染前体的低球蛋白血症在服用抗药物 (AED) 的小队伍中已被观察到.
研究的目的:
- 为了调查AED使用与低胺球蛋白血症之间的关联.
- 为了识别与低血糖球蛋白血症相关的特定AED.
- 探索潜在的因果关系和暴露-反应效应.
主要方法:
- 在苏格兰东北部 (2009-2021) 采用连接的例行健康数据 (生物化学,处方,发病率) 的无与伦比的病例对照研究.
- 病例以低于参考范围的免疫球蛋白水平来定义;对照组具有正常/高水平.
- 经年龄,性别和并发症调整后的后勤回归分析;针对特定免疫球蛋白类型 (IgA,IgM,IgG) 和累积暴露的分析.
主要成果:
- 使用AED与降甘球蛋白血症的风险增加有关 (aOR 1.20).
- 芬伊托因,卡巴马西平和拉莫特里金与低IgA有着强烈的关联.
- 有证据表明,AED使用和低胺球蛋白血症 (包括低IgA和IgG) 之间存在暴露-反应关系.
结论:
- 抗胰岛素抑制剂可能会增加低血球蛋白血症的风险,对免疫球蛋白类有不同的影响.
- 观察到的暴露-反应关系表明AEDs和低胺球菌血症之间存在潜在的因果关系.
- 建议对在AED治疗中出现复发性感染的患者进行免疫球蛋白水平的临床监测.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Transcytosis of IgG
2.8K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K
Antiepileptic Drugs: Glutamate Antagonists
407
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
407
Bias in Epidemiological Studies
339
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
339
Antiepileptic Drugs: Potassium Channel Activators
203
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
203
Antiepileptic Drugs: GABAergic Pathway Potentiators
446
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
446


